Aristotle University Of Thessaloniki (AUTH)
Ο ρόλος της ασύμμετρης διμεθυλαργινίνης (ADMA) στην παθογένεια της νεφρικής ανεπάρκειας σε ασθενείς με αυτοσωματική επικρατούσα πολυκυστική νόσο νεφρών (ΑΕΠΚΝ)
Abstract
dc:descriptionADPKD is the most frequently occurring inherited disorder that causes CKD worldwide, leading to about 5% of patients in the final stage, both in Europe and North America. CKD is a serious clinical event with a significant increase in morbidity and mortality. The mechanisms causing CKD progression are not fully understood and still under investigation.The known theory is that decreasing the normal parenchyma from the pressure of renal cysts as they increase in size. However in experimental studies has been shown that decompressing of cysts did not improve renal function or delay the progression of renal damage. Also CRISP study found that renal blood flow (ie vascular resistance) is an independent predictor, stressing the importance of vasoconstriction and vascular remodeling.Histologically it is characterized by progressively worsening vascular sclerosis of the afferent arteriole, interlobular arteries and interstitial inflammation and interstitial fibrosis. Even in patients with normal or near normal renal function vasodilation depending on the NO activity of the endothelium is defected in small subcutaneous vessels compared to healthy age-matched. The reduction of the bioavailability of NO obviously leads to chronic vasoconstriction and subsequent vascular sclerosis.It seems quite likely that the failure of NO contributes to the progression of kidney damage and eventually leads to nephrosclerosis and end stage CKD. Much interest is growing in recent years around the methylarginines and especially ADMA. It is an endogenous inhibitor of the NO synthases and impairs endothelium-dependent vasodilation.There are a large number of data linking ADMA with proteinuria and hypertension, which are classical CKD progression factors. There are also enough evidence about ADMA being directly involved in the progression of CKD. ADMA may hold causative role in the development of kidney disease.The purpose of this study was the determination of ADMA levels in two groups of patients with ADPKD with preserved renal function (eGFR> 70ml / min) and impaired renal function (eGFR = 45-70ml / min) and compare them both with same demographic characteristics adults without ADPKD and investigate correlations with renal function levels and levels of oxidative stress. Our aim was to investigate causal link between ADMA with decreasing renal function as a possible pathogenetic mechanism causing kidney damage and progression of CKD in this category of patients.The originality of this study is to investigate the presence of increased ADMA in the early stages of ADPKD as possible mechanistic pathway for the induction and progression of renal damage. Also we investigate the presence of endothelial dysfunction from the early stages as it appears to be a special feature. Finally, we investigate the presence of oxidative stress in early stages which most likely is involved in the pathophysiology of endothelial dysfunction and renal failure.After the analysis, the following results and conclusions emerged. a) Elevated ADMA levels appear very early in patients with ADPKD. b) ADMA levels correlate positively with the early display of oxidative stress and further increase with deteriorating. c) This research supports the view that ADMA mechanisms are involved in the induction and progression of renal damage in ADPKD.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Raptis, Vasileios
- Ράπτης, Βασίλειος
Subjects
dc:subject × 12- Αυτοσωματική επικρατούσα πολυκυστική νόσος νεφρών
- Χρόνια νεφρική νόσος
- Ασύμμετρη διμεθυλαργινίνη
- Οξειδωτικό stress
- Autosomal dominant polycystic kidney disease
- Chronic kidney disease
- Asymmetric dimethylarginine
- Oxidative stress
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/35847